Time filter

Source Type

PubMed | Mahidol University, University of Sfax, Chiang Mai University and Queen Savang Vadhana Memorial Hospital
Type: | Journal: Neuropsychiatric disease and treatment | Year: 2016

Residual symptoms of depressive disorder are major predictors of relapse of depression and lower quality of life. This study aims to investigate the prevalence of residual symptoms, relapse rates, and quality of life among patients with depressive disorder.Data were collected during the Thai Study of Affective Disorder (THAISAD) project. The Hamilton Rating Scale for Depression (HAMD) was used to measure the severity and residual symptoms of depression, and EQ-5D instrument was used to measure the quality of life. Demographic and clinical data at the baseline were described by mean standard deviation (SD). Prevalence of residual symptoms of depression was determined and presented as percentage. Regression analysis was utilized to predict relapse and patients quality of life at 6 months postbaseline.A total of 224 depressive disorder patients were recruited. Most of the patients (93.3%) had at least one residual symptom, and the most common was anxiety symptoms (76.3%; 95% confidence interval [CI], 0.71-0.82). After 3 months postbaseline, 114 patients (50.9%) were in remission and within 6 months, 44 of them (38.6%) relapsed. Regression analysis showed that residual insomnia symptoms were significantly associated with these relapse cases (odds ratio [OR] =5.290, 95% CI, 1.42-19.76). Regarding quality of life, residual core mood and insomnia significantly predicted the EQ-5D scores at 6 months postbaseline (B =-2.670, 95% CI, -0.181 to -0.027 and B =-3.109, 95% CI, -0.172 to -0.038, respectively).Residual symptoms are common in patients receiving treatment for depressive disorder and were found to be associated with relapses and quality of life. Clinicians need to be aware of these residual symptoms when carrying out follow-up treatment in patients with depressive disorder, so that prompt action can be taken to mitigate the risk of relapse.


Jantarapakde J.,Red Cross | Phanuphak N.,Red Cross | Chaturawit C.,Red Cross | Pengnonyang S.,Red Cross | And 7 more authors.
AIDS Patient Care and STDs | Year: 2014

Metabolic syndrome (MS), a group of interrelated risk factors for cardiovascular diseases (CVD) and type 2 diabetes, has been increasingly reported among HIV-infected patients. Data on the prevalence and risk factors for MS among HIV-1 infected Thai adults are limited. The study collected cross-sectional data from 580 HIV-1 infected adults-46.2% were men and 71% were antiretroviral therapy (ART)-experienced. The majority (78.8%) of them used non-nucleoside reverse transcriptase inhibitor-based regimens. Data on lipid profiles, fasting blood glucose, CD4 count, HIV RNA, antiretroviral therapy (ART), anthropometry, food intake, and exercise were recorded. MS was defined using American Heart Association/National Heart Lung and Blood Institute criteria. Overall prevalence of MS was 22.2%; 15.9% in ART-naý̈ve group vs. 24.9% in ART-experienced group, p = 0.018. Significant risk factors for MS in multivariate analyses included age ≥35 years (odds ratio, OR, 4.2, 95%CI 1.6-11.0, p = 0.004), high cholesterol (OR 4.7, 95%CI 1.7-12.9, p = 0.002), and living outside Bangkok (OR 4.2, 95%CI 1.6-10.8, p = 0.003) in the ART-naý̈ve group, and female gender (OR 1.7, 95%CI 1.0-2.8, p = 0.05), lipodystrophy (OR 1.8, 95%CI 1.0-3.0, p = 0.032), high cholesterol (OR 1.9, 95%CI 1.1-3.1, p = 0.015), and food insecurity (OR 1.8, 95%CI 1.0-3.3, p = 0.05) in the ART-experienced group. All variables, except for female gender in the ART-experienced group, remained significantly associated with MS in a model where lipodystrophy was excluded. We concluded that MS was common among HIV-1-infected Thai adults. As HIV-infected patients get older, early screening and intervention, such as ART modification to avoid lipodystrophy, may reduce MS and CVD-related morbidities and mortalities in long-term care. © 2014 Mary Ann Liebert, Inc.


Permpalung N.,Columbia University | Wongrakpanich S.,Queen Savang Vadhana Memorial Hospital | Korpaisarn S.,Mahidol University | Tanratana P.,Mahidol University | And 2 more authors.
Vaccine | Year: 2013

Rabies is a fatal infectious disease. Because prevention is the key management for rabies, many vaccination regimens have been developed and used worldwide. The aims for developing rabies vaccination regimens include decreasing the number and amount of dosages, decreasing the duration and the number of clinical visits, and reducing cost. Interestingly, some intradermal (ID) regimens have proved to be as effective as the standard intramuscular (IM) regimens, and have been increasingly used in developing countries because they are less expensive. In this article, we reviewed rabies vaccines based on results obtained from clinical trials and international treatment guidelines for post-exposure prophylaxis, pre-exposure prophylaxis for the high risk group, and booster vaccination. © 2013 Elsevier Ltd.


Kanchanatawan W.,Lerdsin General Hospital | Arirachakaran A.,Police General Hospital | Chaijenkij K.,Mahidol University | Prasathaporn N.,Queen Savang Vadhana Memorial Hospital | And 3 more authors.
Knee Surgery, Sports Traumatology, Arthroscopy | Year: 2016

Purpose: To compare the clinical outcomes of osteoarthritis indices (WOMAC and Lequesne scores) and adverse events in the treatment of osteoarthritis (OA) of the knee with platelet-rich plasma (PRP) versus hyaluronic acid (HA) or placebo. Methods: A systematic review and meta-regression were performed to compare outcomes between PRP injections versus HA or placebo. Relevant randomized control trials were identified from Medline and Scopus from date of inception to 13 August 2015. Results: Nine of 551 studies were eligible; 6, 5, 5, 5, 2, 2, 2 and 7 studies were included in pooling of WOMAC total, pain, stiffness and function scores, Lequesne score, IKDC score, EQ-VAS score and adverse events in OA knee patients, respectively. The PRP injections had −15.4 (95 % CI −28.6, −2.3, p = 0.021), lower mean WOMAC total scores, and 8.83 (95 % CI 5.88, 11.78, p < 0.001), 7.37 (95 % CI 4.33, 10.05, p = 0.021) higher mean IKDC and EQ-VAS scores when compared to HA injections. However, PRP injections had no significant differences in WOMAC pain, stiffness and function scores, as well as Lequesne score and adverse events when compared to HA or placebo. Conclusion: In short-term outcomes (≤1 year), PRP injection has improved functional outcomes (WOMAC total scores, IKDC score and EQ-VAS) when compared to HA and placebo, but has no statistically significant difference in adverse events when compared to HA and placebo. This study suggests that PRP injection is more efficacious than HA injection and placebo in reducing symptoms and improving function and quality of life. It has the potential to be the treatment of choice in patients with mild-to-moderate OA of the knee who have not responded to conventional treatment. Level of evidence: I. © 2015, European Society of Sports Traumatology, Knee Surgery, Arthroscopy (ESSKA).


Prasathaporn N.,Queen Savang Vadhana Memorial Hospital | Kuptniratsaikul S.,Queen Savang Vadhana Memorial Hospital | Kongrukgreatiyos K.,Queen Savang Vadhana Memorial Hospital
Arthroscopy Techniques | Year: 2013

Meniscus root tear leads to circumferential hoop tension loss and increases femorotibial contact force, which causes irreversible cartilage degeneration. Biomechanical studies have shown that meniscus root repair provides better femorotibial contact force than meniscectomy. Many techniques for meniscus root repair have been published in recent years. The soft suture anchor is widely used in the glenoid labral repair. It is a small low-profile soft anchor. This article presents a new and simple technique of lateral meniscus root repair using the small soft anchor, which results in an anatomic and more vertical anchor position. It avoids instrument-related complications, such as cartilage delamination, material reaction, metal retention, and hard suture anchor pullout. © 2013 .


Khanasuk Y.,Queen Savang Vadhana Memorial Hospital | Tanavalee A.,Chulalongkorn University
Journal of the Medical Association of Thailand | Year: 2015

Background: Low urine output (LUO) for six hours is defined as the stage that is at risk of acute renal failure. Major surgeries with a bloodless field, such as total knee arthroplasty (TKA), may be associated with LUO; however, there has been no study addressing this point. The present study evaluated the incidence of LUO and the effect of fluid balance on LUO in TKA patients during the first 24 hours after surgery. Material and Method: The authors retrospectively evaluated 257 uncomplicated patients undergoing unilateral TKA during the first 24 hours after surgery. Patients’ demographic data, intra-operative intravenous (IV) fluid replacement, postoperative IV fluid replacement, oral fluid intake, total fluid intake, postoperative urine output, blood collected from the drain, and the total visible fluid output during the first 24 hours after surgery were collected and evaluated. Results: The incidence of LUO was 19.1% (49/257) in the studied group. There were no significant differences in patients’ demographic data between the LUO and normal urine output (NUO) groups. Comparing the LUO and NUO groups, the LUO group had a lower volume of intra-operative fluid replacement, with statistical significance. There were no differences in postoperative IV fluid replacement and postoperative oral fluid intake between groups. Although 80.5% of the studied group had IV fluid replacement at a less than ideal level, at discharge there was no patient suffering from renal complications related to LUO. Discussion and Conclusion: Urine output is one of the common monitoring parameters of fluid balance in the perioperative period; it should be ≥0.5 mL/kg/h. Prolonged low urine output for six hours and for 12 hours are categorized as causing risk and injury to the kidney, respectively. The incidence of LUO at our institution during the first 24 hours after TKA is not uncommon and is significantly related to intra-operative fluid replacement. Fortunately, all LUO patients had further fluid replacement, resulting in no renal complications at discharge. As eighty percent of patients had less than ideal fluid replacement, and patients having LUO during the first 24 hours had a significantly lower volume of intra-operative fluid replacement, the authors propose reconsidering perioperative fluid replacement in TKA patients, especially intra-operative IV fluid to avoid LUO. © 2015, Medical Association of Thailand. All rights reserved.


Akawatcharangura P.,Queen Savang Vadhana Memorial Hospital | Taechakraichana N.,Chulalongkorn University | Osiri M.,Chulalongkorn University
Lupus | Year: 2016

Background: Systemic lupus erythematosus (SLE) is an autoimmune disease that affects most women of reproductive age. The prevalence of premature ovarian failure (POF) in SLE patients is higher than that in the general population. However, the data on this condition are limited in Asian countries. Objectives: To determine the prevalence and associated factors of POF in SLE patients who received immunosuppressive therapy. Methods: Women aged 18-40 years who were diagnosed with SLE according to the 1997 revised criteria for the classification of SLE or patients with biopsy-proven lupus nephritis were evaluated. All patients had received at least one of the following immunosuppressive agents: cyclophosphamide (CYC), azathioprine, mycophenolate mofetil, chlorambucil or cyclosporine for more than six months. POF was diagnosed in those who had sustained amenorrhea for more than six consecutive months, with a level of estradiol ≤ 110 pmol/L (30 pg/mL) and follicle stimulating hormone ≥40 IU/L. Results: Ninety two SLE patients were included in this study. Mean age at enrollment was 30 ± 6.9 years and disease duration was 103 ± 67.5 months. The mean Systemic Lupus International Collaborating Clinics/ American College of Rheumatology (SLICC/ACR) damage index was 1.7 ± 1.7. Seventy five patients (82%) had lupus nephritis. Sixty four patients (70%) received CYC. Eleven patients (12%) with POF were observed. For the binary logistic regression model, CYC cumulative dosage of more than 10 g was the only independent risk factor of POF (hazard ratio 17.0, 95%CI 1.96-147.72, p = 0.01). Conclusions: From our data, 12% of SLE patients developed POF. A cumulative dose of CYC of more than 10 g was the only risk factor for POF. To prevent these events, systematic evaluation and early recognition of POF should be promoted in the care of SLE patients. © The Author(s) 2015.


PubMed | Srinakarin Hospital, Ramathibodi Hospital, Queen Savang Vadhana Memorial Hospital, Lerdsin General Hospital and 2 more.
Type: Journal Article | Journal: Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA | Year: 2016

To compare the clinical outcomes of osteoarthritis indices (WOMAC and Lequesne scores) and adverse events in the treatment of osteoarthritis (OA) of the knee with platelet-rich plasma (PRP) versus hyaluronic acid (HA) or placebo.A systematic review and meta-regression were performed to compare outcomes between PRP injections versus HA or placebo. Relevant randomized control trials were identified from Medline and Scopus from date of inception to 13 August 2015.Nine of 551 studies were eligible; 6, 5, 5, 5, 2, 2, 2 and 7 studies were included in pooling of WOMAC total, pain, stiffness and function scores, Lequesne score, IKDC score, EQ-VAS score and adverse events in OA knee patients, respectively. The PRP injections had -15.4 (95% CI -28.6, -2.3, p=0.021), lower mean WOMAC total scores, and 8.83 (95% CI 5.88, 11.78, p<0.001), 7.37 (95% CI 4.33, 10.05, p=0.021) higher mean IKDC and EQ-VAS scores when compared to HA injections. However, PRP injections had no significant differences in WOMAC pain, stiffness and function scores, as well as Lequesne score and adverse events when compared to HA or placebo.In short-term outcomes (1year), PRP injection has improved functional outcomes (WOMAC total scores, IKDC score and EQ-VAS) when compared to HA and placebo, but has no statistically significant difference in adverse events when compared to HA and placebo. This study suggests that PRP injection is more efficacious than HA injection and placebo in reducing symptoms and improving function and quality of life. It has the potential to be the treatment of choice in patients with mild-to-moderate OA of the knee who have not responded to conventional treatment.I.


PubMed | Chulalongkorn University and Queen Savang Vadhana Memorial Hospital
Type: Journal Article | Journal: Lupus | Year: 2016

Systemic lupus erythematosus (SLE) is an autoimmune disease that affects most women of reproductive age. The prevalence of premature ovarian failure (POF) in SLE patients is higher than that in the general population. However, the data on this condition are limited in Asian countries.To determine the prevalence and associated factors of POF in SLE patients who received immunosuppressive therapy.Women aged 18-40 years who were diagnosed with SLE according to the 1997 revised criteria for the classification of SLE or patients with biopsy-proven lupus nephritis were evaluated. All patients had received at least one of the following immunosuppressive agents: cyclophosphamide (CYC), azathioprine, mycophenolate mofetil, chlorambucil or cyclosporine for more than six months. POF was diagnosed in those who had sustained amenorrhea for more than six consecutive months, with a level of estradiol110pmol/L (30pg/mL) and follicle stimulating hormone 40IU/L.Ninety two SLE patients were included in this study. Mean age at enrollment was 306.9 years and disease duration was 10367.5 months. The mean Systemic Lupus International Collaborating Clinics/ American College of Rheumatology (SLICC/ACR) damage index was 1.71.7. Seventy five patients (82%) had lupus nephritis. Sixty four patients (70%) received CYC. Eleven patients (12%) with POF were observed. For the binary logistic regression model, CYC cumulative dosage of more than 10g was the only independent risk factor of POF (hazard ratio 17.0, 95% CI 1.96-147.72, p=0.01).From our data, 12% of SLE patients developed POF. A cumulative dose of CYC of more than 10g was the only risk factor for POF. To prevent these events, systematic evaluation and early recognition of POF should be promoted in the care of SLE patients.


PubMed | Red Cross, Chiangrai Prachanukroh Hospital, Boston College, National Pediatric Hospital and 7 more.
Type: Journal Article | Journal: Journal of virus eradication | Year: 2016

Monocytes play a central role in HIV neuropathogenesis, but there are limited data on monocyte subsets and markers of monocyte activation in perinatally HIV-infected children.To determine the relationship between monocyte subsets, the sCD163 monocyte activation marker, and neuropsychological performance among perinatally HIV-infected children initiating antiretroviral therapy (ART).ART-nave children from the PREDICT study were categorised into two groups: those on ART for 24 weeks (ART group, Baseline demographic and HIV disease parameters were similar between groups. The median age was 6 years, CD4 was 20% (620 cells/mmART significantly reduced sCD163 levels and frequencies of activated and perivascular monocytes. Higher frequencies of these cells correlated with better neuropsychological performance suggesting a protective role of monocyte-macrophage immune activation in perinatal HIV infection in terms of neuropsychological function.

Loading Queen Savang Vadhana Memorial Hospital collaborators
Loading Queen Savang Vadhana Memorial Hospital collaborators